To include your compound in the COVID-19 Resource Center, submit it here.

MBX-8025: Phase II data

A double-blind, international Phase II trial in 26 evaluable PBC patients who had an inadequate response to ursodiol and who completed >=2 weeks of

Read the full 249 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE